ARTICLE

FindCenter AddIcon

Think It’s a Good Time to Start Microdosing? Here’s What You Need to Know

By Kathleen Newman-Bremang — 2020

The party line of the microdosing community is that it helps with feelings of depression and anxiety (depending on the drug and the severity of the illness), and can make general improvements to your day-to-day life — from focus and productivity (it’s a Silicon Valley hack) to sleep and sex drive.

Read on www.refinery29.com

FindCenter Post-Image

The Return of Psychedelics to Counseling: Are We Ready?

Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.

Article
Benjamin Hearn
2020
FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Article
Maureen Meehan
2017
FindCenter AddIcon
FindCenter Post-Image

EMDR Therapy for Anxiety, Panic, PTSD and Trauma

In 1987 psychologist Francine Shapiro developed a new type of psychotherapy known as EMDR, which stands for Eye Movement Desensitization and Reprocessing. EMDR therapy has become a more common treatment in recent years as a treatment option for people suffering from anxiety, panic, PTSD, or trauma.

Article
John Riddle
2020
FindCenter AddIcon
FindCenter Post-Image

Crash Course in the Nature of Mind

Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.

Article
Julie Scharper
FindCenter AddIcon
FindCenter Post-Image

‘60 Minutes’ Segment Explores Psychedelics Research at Johns Hopkins

Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.

Article
60 Minutes
2019
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Studies and the Religious Experience: An Interview with Roland Griffiths, Ph.D.

We spoke about his research with psilocybin, his interest in spiritual experiences, and how psychedelics may provide help for people who are dying.

Article
David Jay Brown with Louise Reitman
FindCenter AddIcon
FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

Magic Mushrooms Expand the Mind by Dampening Brain Activity

A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.

Article
Maia Szalavitz
2012
FindCenter AddIcon

EXPLORE TOPIC

Microdosing